ASCO Guidelines

180 Jaksot

1. Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline

   Julkaistiin: 3.9.2019
2. Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer Guideline Update

   Julkaistiin: 5.8.2019
3. Medication-Related Osteonecrosis of the Jaw Guideline

   Julkaistiin: 22.7.2019
4. Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update

   Julkaistiin: 17.6.2019
5. Potentially Curable Pancreatic Adenocarcinoma Guideline Update

   Julkaistiin: 10.6.2019
6. Use of Biomarkers to Guide Decisions on Adjuvant Therapy for Early-Stage Invasive Breast Cancer Guideline Update

   Julkaistiin: 31.5.2019
7. Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer PCO

   Julkaistiin: 25.4.2019
8. Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer Guideline

   Julkaistiin: 15.4.2019
9. Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents Guideline

   Julkaistiin: 10.4.2019
10. Treatment of Multiple Myeloma Guideline

    Julkaistiin: 1.4.2019
11. Anticonvulsant Prophylaxis and Steroid Use in Adults with Metastatic Brain Tumors Endorsement

    Julkaistiin: 18.3.2019
12. Adjuvant Therapy for Resected Biliary Tract Cancer Guideline

    Julkaistiin: 11.3.2019
13. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline

    Julkaistiin: 27.2.2019
14. Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline

    Julkaistiin: 25.2.2019
15. Early Detection for Colorectal Cancer Resource-Stratified Guideline

    Julkaistiin: 25.2.2019
16. Safe Handling of Hazardous Drugs: ASCO Standards

    Julkaistiin: 8.1.2019
17. Initial Diagnostic Workup of Acute Leukemia Guideline

    Julkaistiin: 3.12.2018
18. Evaluating Susceptibility to Pancreatic Cancer PCO

    Julkaistiin: 20.11.2018
19. Adjuvant Endocrine Therapy for Women with Hormone Receptor Positive Breast Cancer Guideline

    Julkaistiin: 19.11.2018
20. Hypofractionated Radiation Therapy for Localized Prostate Cancer Guideline

    Julkaistiin: 11.10.2018